When the Medium Is Alive

As artists work with bacteria, fungi, cells and engineered matter, the studio begins to resemble a laboratory. Aesthetics can no longer be separated from care, containment, consent and the possibility that the material will change after the artist has stopped touching it.

A sculpture made from stone can crack. A photograph can fade. A film can become unreadable when its format disappears. Living material introduces a different condition: it can grow, metabolize, mutate, reproduce, contaminate, die or enter into relations its maker did not predict.

This makes bioart more than art with an unusual material. It changes the ethical structure of making.

In late 2025, the artist Santtu Laine worked in a Tokyo art-and-science residency with seaweed-based bioplastics and marine bacteria. His research explored whether bacteria could bio-etch and shape a material derived from seaweed while connecting laboratory experimentation to Japanese traditions of processing tengusa and producing kanten. The project placed contemporary biomaterial research beside a long cultural history of working with algae.

Elsewhere, artists and designers are growing bacterial cellulose, kombucha sheets, mycelium structures and pigments produced by microorganisms. Research laboratories are developing synthetic cells, living textiles and engineered material systems with capacities for repair, sensing or controlled production.

The word "living" is attractive. It suggests renewal, responsiveness and ecological intelligence. It can also become a form of green marketing that conceals energy, sterilization, nutrient inputs, plastic laboratory waste and biological risk.

A material is not sustainable simply because an organism participated in making it.

The central challenge for bioart is therefore double. Artists must learn enough biology to work responsibly, while refusing the idea that scientific legitimacy should determine the value of art. The laboratory can become an artistic medium, but it remains a place where errors can have consequences beyond appearance.

The central answer

Bioart becomes credible when living systems are treated neither as decorative novelty nor as obedient production tools. Artists need clear protocols for sourcing, containment, consent, maintenance, public communication and disposal. They must distinguish bio-based materials from living and genetically engineered systems, and they should document what the organism requires, what risks are plausible and what happens if the work escapes, changes or dies. In living art, care is not external to the medium. Care is one of its formal properties.

Four meanings hidden inside the word bio

Public discussion frequently places several different practices under one label. They carry very different responsibilities.

Bio-based material

A bio-based material is derived wholly or partly from biological resources. A dried seaweed polymer, plant fiber or processed fungal composite may no longer be alive. It can still raise questions about cultivation, additives, energy, land and disposal, but it does not require ongoing biological containment.

Living material

A living material contains organisms or cells that remain metabolically active. It may grow, respond, repair or decay. The work's environment becomes part of its function.

Engineered living material

An engineered living material uses biological systems that have been selected, assembled or modified to produce defined behavior. This can include microorganisms that generate pigments, bind minerals or respond to environmental signals.

Synthetic cell or synthetic biological system

Synthetic-cell research attempts to construct life-like cellular systems from biomolecular components or redesign cellular architecture. These systems can blur the boundary between chemical assembly and biological life. Their governance may not fit neatly into existing categories.

An artist should identify which category describes the actual work. Calling a dead biomaterial "living" may be poetically convenient but scientifically misleading. Calling an ordinary fermentation process "synthetic biology" can exaggerate technical novelty and obscure older cultural knowledge.

Precision is part of respect.

The laboratory is not a neutral studio

A studio can tolerate mess. A biological laboratory organizes mess through protocols.

Surfaces, waste streams, temperature, storage, sterilization and personal protective equipment are designed to reduce uncertain exposure. A Biosafety Level 1 facility may support work with organisms not known to consistently cause disease in healthy adults, but "low risk" is not "no responsibility."

The Bioart Society's 2026 Tokyo residency offered access to a BSL-1 laboratory and fabrication facilities. That infrastructure is important because it places artistic experimentation within a space capable of supporting controlled work. It also reveals an inequality. Artists with access to laboratories, mentors and institutional partnerships can pursue forms of research unavailable to practitioners working alone.

Do-it-yourself biology and open wet labs have widened access to biotechnology. Waag's BioHack Academy, for example, combines critical biotechnology, microbiology, gene editing and open-source laboratory equipment. Fabricademy connects textiles, digital fabrication and biology through topics such as bacterial dyes, mycelium, bioplastics and wearable systems.

Access should expand, but access must include competence. A culture of experimentation becomes irresponsible when safety is treated as bureaucratic resistance rather than shared knowledge.

Artists do not need to become research scientists. They need enough literacy to recognize when a question exceeds their training and requires collaboration.

When bacteria becomes a tool

The phrase "using bacteria" can make a living system sound equivalent to a brush or printer. The analogy is incomplete.

A brush has no metabolism. Bacteria respond to nutrients, temperature, competition and contamination. Their behavior can vary between batches. They may produce unexpected by-products. The work may depend on keeping them alive or on stopping them at a precise moment.

This instability can carry artistic meaning. A bio-etched surface records not only design but negotiation among organism, material and environment. Bacterial pigment can make color inseparable from growth conditions. A living textile can transform maintenance into performance.

Yet an artist should ask what kind of instrumental relation the work establishes.

• Is the organism treated only as a hidden factory?
• Does the work reveal its biological agency and needs?
• Is the organism killed when the desired surface appears?
• Is that death conceptually acknowledged?
• Does the work depend on a romantic idea of cooperation that ignores control?

Bioart need not assign human rights to microbes. It should avoid describing biological life as frictionless material intelligence while concealing the systems that confine and exploit it.

Learning from traditional material knowledge

Biotechnology is often presented as a break with the past. Many bio-based practices have much older histories.

Fermentation, natural dyeing, tanning, papermaking, mycelial food production, seaweed processing and plant-fiber construction involve generations of observation and cultural adaptation. Contemporary laboratories may isolate mechanisms that traditional practitioners understood through experience, even when the two knowledge systems use different language.

Laine's research with kanten is important for this reason. Seaweed bioplastic does not begin with a novel polymer recipe downloaded from a material library. It intersects with regional harvesting, processing, cuisine and craft.

Artists working with such materials should examine:

• who developed the underlying practice;
• whether knowledge belongs to a community or lineage;
• how materials are harvested;
• whether commercial or artistic use creates pressure on ecosystems;
• who is credited and compensated;
• whether laboratory terminology erases local expertise.

A contemporary biomaterial can be technologically innovative and culturally extractive at the same time.

Synthetic cells and the problem of categories

The 2026 National Academies report Supporting Responsible Innovation of Synthetic Cells describes a field whose risks may resemble those of existing chemical and microbial systems while appearing in new combinations. Synthetic cells can blur system boundaries and create uncertainty for risk assessment and oversight.

One example in the report concerns a cell-like system without DNA that nevertheless displays life-like behavior. Such a construct raises a basic governance question: should it be regulated as a chemical system, a biological system or something between them?

For artists, the philosophical attraction is obvious. Synthetic cells disturb categories such as alive and non-living, natural and artificial, organism and machine. But category disturbance in an artwork does not remove the need for practical classification. Someone must still determine handling, transport, display and disposal.

The National Academies recommends adaptive, evidence-based and proportionate governance, stronger research infrastructure, modernized oversight, transparency and public engagement. Those principles are useful for culture as well as science.

A museum considering a work with synthetic cells should not rely on the artist's assurance that the system is conceptually harmless. It should seek appropriate expertise, document plausible failure modes and establish who can stop the work if conditions change.

Biosecurity without sensationalism

Biological risk is easily sensationalized. Popular culture imagines catastrophic organisms escaping from laboratories. Most bioart projects do not approach that level of hazard.

Minimizing panic, however, is not the same as dismissing risk.

The World Health Organization's framework for the responsible use of the life sciences emphasizes governance of dual-use research: work intended for beneficial purposes that could be misapplied. In 2026, WHO-supported initiatives continued to translate this guidance into national practice, including workshops on dual-use oversight.

Artists may encounter dual-use questions when they publish protocols, work with genetic modification, visualize sensitive data or develop low-cost biological tools. Open culture is valuable, but complete procedural transparency can create tension when methods are capable of misuse.

A responsible project evaluates:

• the organism or biological components;
• the intended manipulation;
• the scale of work;
• the environment of display;
• the expertise of participants;
• accidental exposure or release;
• whether detailed publication creates additional risk;
• who has authority to assess the project.

This evaluation should be proportionate. Treating every bacterial artwork as a security threat would suppress legitimate culture and public engagement. Treating artistic intention as exemption would be equally careless.

The aesthetics of maintenance

Living work makes maintenance visible.

A museum accustomed to stabilizing objects may need to feed, water, illuminate or monitor a piece. Temperature and humidity become active parameters rather than background climate controls. Staff may need to cultivate replacement material or decide when a biological cycle has ended.

The work's identity can depend on those decisions.

Consider several possibilities:

• A living colony is the artwork, and its death ends the work.
• The colony is replaceable, while a protocol and visual pattern define continuity.
• The biological process creates a non-living object, and only the result is collected.
• The institution acquires a license to re-perform the process.
• The work includes both a living phase and an archived remnant.

Each model demands a different acquisition agreement.

Conservators should know whether variation is expected, whether contamination changes the work, whether failed growth can be repeated and how the artist defines an acceptable result. A museum cannot preserve living art through refrigeration alone. It must preserve knowledge, authority and conditions of care.

Maintenance also redistributes authorship. Technicians and conservators may shape the visible work each time it is grown or installed. Their labor should be acknowledged rather than treated as invisible service.

Death is part of the medium

Living art eventually confronts death, whether through design, accident or institutional closure.

Some works end when an organism dies. Others require organisms to be killed for safe display. A microbial process may be fixed, dried or sterilized to produce a stable object. An exhibition may be prohibited from transporting a living culture across a border.

Artists should not hide these endings behind the language of vitality.

A responsible work can state:

• whether living material remains alive during exhibition;
• what conditions sustain it;
• whether organisms are terminated;
• what method is used;
• how waste is decontaminated;
• what happens after the exhibition;
• whether the work can be regenerated.

Death can be conceptually central, but it must also be operationally planned.

Sustainability requires a full material account

Biomaterials are frequently presented as alternatives to plastics, leather, concrete or synthetic dyes. Some offer genuine environmental advantages. Others remain experimental or depend on inputs that complicate the claim.

A material assessment should consider:

• source and renewability of feedstock;
• agricultural land, water and biodiversity impacts;
• energy and temperature requirements;
• nutrient media and additives;
• sterilization;
• laboratory plastics;
• processing and finishing;
• durability and repair;
• biodegradation conditions;
• toxicity of pigments, binders or coatings;
• transport and scale.

A mycelium composite coated in a persistent resin may no longer biodegrade as expected. A bacterial pigment grown in a laboratory can require nutrients, heat and sterile disposables. A seaweed polymer may be renewable while its extraction affects local ecosystems or livelihoods.

The 2026 Learning Materials residency organized by the Bioart Society and partners explicitly included waste, circular economies, material legacies, biomaterials and greenwashing among its themes. That combination is important. The field is becoming aware that biological appearance can be used to market sustainability without sufficient evidence.

Art can help expose that contradiction rather than reproducing it.

Consent beyond the human subject

Human-tissue art raises familiar questions about donor consent, ownership, privacy and future use. Living materials introduce additional forms of consent and authority.

If a project uses human cells, bodily fluids or genetic information, the donor must understand what will be created, displayed, stored and potentially reproduced. Consent for scientific analysis does not automatically include artistic exhibition. Anonymization may be difficult when genomic data is involved.

When cultural or ecological knowledge comes from a community, individual permission may be insufficient. A material process can have collective significance. Indigenous and local knowledge should not be extracted into a laboratory protocol without appropriate governance and benefit.

Non-human organisms cannot consent in the human legal sense, but their treatment still carries ethical consequences. The relevant questions include welfare, ecological relation and whether the work creates avoidable harm.

Bioart therefore expands consent from a signed form into a continuing relationship.

A nine-part protocol for living artwork

Before exhibition or acquisition, a living or biologically active work should have a documented protocol covering nine areas.

1. Biological identity

Name the organism, cell system or material accurately, including strain or relevant modification where appropriate.

2. Source and authority

Record where it came from, who supplied it, which licenses or permissions apply and whether community knowledge is involved.

3. Containment

Define the physical and procedural measures that prevent unintended exposure or release.

4. Care

Specify nutrients, temperature, light, humidity, monitoring and trained personnel.

5. Consent and rights

Document donor consent, participant rights, cultural permissions and limitations on future use.

6. Failure and emergency

Describe contamination, unexpected growth, equipment failure, exposure and the authority to stop the work.

7. Public communication

Explain what is alive, altered or synthetic without exaggeration, and disclose material risks proportionately.

8. Death, disposal and regeneration

State how organisms or materials are terminated, decontaminated, discarded, archived or regrown.

9. Preservation and change

Define which biological variations are acceptable and what constitutes the same work across repeated installations.

This protocol does not turn art into compliance paperwork. It makes the relations sustaining the work visible.

The laboratory as public culture

Bioart can bring life-science questions into public experience before they are settled by policy or commercial adoption. It can make synthetic cells, microbial production and ecological interdependence available to people who would never enter a research laboratory.

That public role is valuable when the work refuses both celebration and panic.

The artist can ask what kind of life is being designed, who controls the infrastructure, which materials are called natural and how care changes when a work is alive. These are aesthetic questions because they concern form, relation, time and perception. They are political questions because they concern authority and risk.

The future of bioart will not be secured by increasingly spectacular biological materials. It will depend on whether artists can create forms in which scientific complexity, cultural history and ethical responsibility remain present together.

When the medium is alive, the artist does not finish by stepping away. The work continues to ask who will care for it, who may alter it and how its life is allowed to end.

Six questions readers may ask

1. Is every artwork made from biological material bioart?

Not necessarily. The term can refer broadly to art engaging with life processes, biotechnology or biological knowledge, but a work made from wood, wool or dried plant fiber does not automatically become bioart. The more useful question is how biology functions in the work. Is the material alive? Is a biological process generating form? Is the artist critically engaging with life science, ecology or biotechnology? Clear description is better than using "bio" as a prestige label.

2. Can living artworks be safely shown in ordinary museums?

Some can, provided that risks are properly assessed and the institution has appropriate facilities and expertise. Low-risk organisms may be displayed in contained systems, while other projects require specialized laboratories or should not be shown live. The museum needs protocols for handling, monitoring, emergencies, cleaning and waste. It should also confirm legal transport and exhibition requirements. Artistic intention does not replace biosafety review.

3. Who owns a living organism used in an artwork?

Ownership depends on the organism, jurisdiction, supplier terms, genetic modification, patents and contracts. An artist may own a physical culture without owning all intellectual-property rights associated with a strain or method. Human cells raise separate consent and privacy issues. Community knowledge can create ethical obligations beyond formal property law. Acquisition agreements should distinguish the physical biological material, the artistic work, the protocol and the rights to reproduce or regenerate it.

4. Are biomaterials always more sustainable than conventional materials?

No. Their environmental performance depends on feedstock, cultivation, energy, nutrients, additives, laboratory waste, durability, finishing and disposal. Some biomaterials can reduce fossil inputs or support circular systems. Others require intensive processing or coatings that undermine biodegradability. Artists and designers should make specific, bounded comparisons rather than using biological origin as automatic proof of sustainability.

5. How can a museum preserve an artwork that grows or dies?

It must first define what constitutes the work. The institution may preserve a living culture, a protocol for regrowth, a fixed result, an archived sample or the right to re-perform a biological process. The artist should specify acceptable variation, care conditions, contamination rules, replacement material and the meaning of death. Conservation will often preserve knowledge and authority as much as physical matter.

6. Does bioart create a serious biosecurity risk?

Most bioart uses low-risk organisms and processes, but risk depends on the actual system rather than the artistic label. Projects involving genetic modification, pathogens, sensitive protocols or environmental release require greater scrutiny. Institutions should apply proportionate biosafety and dual-use assessment with qualified experts. Exaggerating danger can stigmatize valuable public engagement; ignoring plausible misuse or exposure can damage trust. Responsible bioart requires informed openness, not sensationalism or denial.

1. National Academies, Supporting Responsible Innovation of Synthetic Cells, April 2026.
2. National Academies, ecological and governance considerations for synthetic cells, 2026.
3. World Health Organization, Technical Advisory Group on responsible use of the life sciences and dual-use research, 2025.
4. WHO, Malaysia advances responsible use of life sciences, April 2026.
5. Bioart Society, Santtu Laine: Tokyo Art and Science Research Residency, January 2026.
6. Bioart Society, Tokyo Art and Science Research Residency, accessed August 2026.
7. Bioart Society, 2026 Tokyo residency open call and BSL-1 facilities, 2026.
8. Bioart Society, Genietta Varsi selected for the 2026 Tokyo residency, March 2026.
9. Bioart Society, Learning Materials artists in residence, December 2025.
10. Bioart Society, Learning Materials collaboration project, June 2025.
11. Bioart Society, Ars Bioarctica residency 2025-2026, accessed August 2026.
12. Waag Academy, BioHack Academy, accessed August 2026.
13. Waag Academy, Fabricademy, 2026-2027 program.
14. Waag, Fabricademy Show 2026, April 2026.